Advertisement

Topics

Zafgen, Inc. Company Profile

14:48 EDT 25th September 2018 | BioPortfolio

Zafgen is pioneering novel obesity therapeutics that directly target fat metabolism to help the body regain and sustain a lean, healthy state. The company’s approach focuses on restoring control of key metabolic processes, releasing stored fat which then is used by the body as fuel. Zafgen’s first generation product, named ZGN-433, is being studied in a Phase 1b clinical trial for its use as a pharmacological alternative to bariatric surgery in the treatment of severe obesity. Zafgen's leadership and scientific advisors include leading experts in obesity, metabolic disorders and medicinal chemistry. Founded in 2005, the company is located in Cambridge, Mass. For more information, visit www.zafgen.com.


News Articles [43 Associated News Articles listed on BioPortfolio]

Zafgen Exec Thomas Hughes Resigns to Take CEO Job at Navitor

Thomas Hughes is leaving Zafgen, which he led for nine years, in order to take the top job at another biotech company. The job change comes 10 months after Hughes resigned as CEO of Zafgen (NASDAQ: ZF...

In The Spotlight: Zafgen

Shares of Zafgen Inc. (ZFGN) are up an impressive 129% year-to-date compared to the 4% gain of the iShares Nasdaq Biotechnology ETF (IBB) index during the same period.

Zafgen nets $56.5mm via FOPO

Zafgen Inc. (therapies for complex metabolic diseases) netted $56.4mm through a follow-on public offering of 8mm common shares at $7.50 each. The company will use some of the proceeds for ongoing deve...

Zafgen nets $64.9mm via FOPO

Zafgen Inc. (therapies for complex metabolic diseases) netted $64.9mm through a follow-on public offering of 9.2mm common shares (including full exercise of the overallotment) at $7.50 each. The compa...

Zafgen: 3 Key Takeaways From ADA Abstracts

Management tracks: Zafgen, Rigel

Kura, Zafgen price follow-ons

Zafgen Set to Join Russell 3000® Index

BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for p...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Zafgen, Inc.

Zafgen is pioneering novel obesity therapeutics that directly target fat metabolism to help the body regain and sustain a lean, healthy state. The company’s approach focuses ...

More Information about "Zafgen, Inc." on BioPortfolio

We have published hundreds of Zafgen, Inc. news stories on BioPortfolio along with dozens of Zafgen, Inc. Clinical Trials and PubMed Articles about Zafgen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zafgen, Inc. Companies in our database. You can also find out about relevant Zafgen, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record